Given the important role of transcription factor Forkhead box C2 (FOXC2) in maintaining stem cell-like features and mesenchymal phenotype, inhibition of FOXC2 expression and subsequent EMT inhibition could restore GLS2 expression as well as glutamine utilization in cancer cells undergoing EMT. The gene discussed is FOXC2; the disease is cancer.